ENX-101
- Generic Name
- ENX-101
ENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal Seizures
- First Posted Date
- 2022-08-01
- Last Posted Date
- 2023-07-06
- Lead Sponsor
- Engrail Therapeutics INC
- Registration Number
- NCT05481905
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
🇺🇸University of Rochester, Rochester, New York, United States
🇺🇸Washington University School of Medicine, Saint Louis, Missouri, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath